COVID-19 vaccination axillary adenopathy detected during breast imaging

An open-access article in ARRS’ American Journal of Roentgenology (AJR) describes the clinical and imaging features of axillary adenopathy detected during screening or diagnostic breast imaging after recent coronavirus disease (COVID-19) vaccination to inform the development of follow-up recommendations.

Read more

COVID-19 vaccination axillary adenopathy detected during breast imaging

Open-access AJR article details clinical and imaging features of adenopathy detected during screening and diagnostic breast mammography, ultrasound, and MRI after recent coronavirus disease vaccination (Pfizer-BioNTech and Moderna)

Read more

Oncotarget: MEK is a promising target in the basal subtype of bladder cancer

“The @Oncotarget authors demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder cancer, and their data indicate that drug screening of 3D cultures provides an important resource for hypothesis generation”

Read more

Mayo Clinic researchers develop test to measure effect of breast cancer gene variants

Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing to determine the clinical importance of many BRCA2 variants of uncertain significance (VUS). The findings were published today in a study in the American Journal of Human Genetics.

Read more

Maryam Lustberg Named Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center

Maryam Lustberg, MD, MPH, has been appointed Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center. She will also join the faculty at Yale Cancer Center as an Associate Professor of Medicine (Medical Oncology).

Read more